RENACOL

• ClinicalTrials.gov ID: NCT03733990
• Status: Completed

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients. A Phase I/II Open Label Single Centre Trial to Assess the Safety,Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon Carcinoma